For research and information-retrieval evaluation only. Not a medical device. Not for diagnosis, treatment, or patient care.

← All tasks
Task B-001 · Type B — Disease → gene association

Which gene is associated with fibrodysplasia ossificans progressiva, and what is the nature of the pathogenic variant?

Difficulty
easy
Rarity stratum
sparse
Evidence type
primary_research + review
MONDO ID
MONDO:0007606
Curator notes

ACVR1 is also known as ALK2 in the literature (both terms appear across gold documents) — an entity-linking system must resolve both names to the same gene.

Generation outcome

Abstained
No
Abstention correct
Yes
Gold in retrieved
3.00
Generation cost
$0.000366
Claims
2
Supported
2
Contradicted
0
Unverifiable
0

Gold documents (4)

  • Fibrodysplasia ossificans progressiva.
    pubmed:18328989not retrievedsource
  • Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis.
    pubmed:34440363retrieved ✓source
  • Fibrodysplasia ossificans progressiva in a 3-year-old female patient.
    pubmed:36867574retrieved ✓source
  • Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva.
    pubmed:41471105retrieved ✓source

Retrieved documents (6)

  • Fibrodysplasia Ossificans Progressiva: A Report of Four Cases.
    pubmed:35475090
  • Fibrodysplasia Ossificans Progressiva: A Case Report.
    pubmed:38576636
  • Fibrodysplasia ossificans progressiva.
    pubmed:12804980
  • Fibrodysplasia ossificans progressiva in a 3-year-old female patient.
    pubmed:36867574gold
  • Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva.
    pubmed:41471105gold
  • Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis.
    pubmed:34440363gold

Generated claims (2)

supportedconfidence 1.00

The gene associated with fibrodysplasia ossificans progressiva is ACVR1 (ALK2).

pubmed:41471105pubmed:34440363pubmed:36867574
supportedconfidence 1.00

The nature of the pathogenic variant is activating mutations that result in a constitutively overactive ALK2 receptor.

pubmed:41471105pubmed:34440363